DUBLIN--(BUSINESS WIRE)--The "China Respiratory Devices Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The major factor broadly acting as a driving factor includes a high prevalence of respiratory diseases in China, a continuation of economic and demographic trends, health-care reform and the policies implanted by the government.
In China, chronic respiratory diseases are the second leading cause of death. It is estimated that over 50% of Chinese men smoke, whereas smoking rates among women are lower in this country. Chronic obstructive pulmonary disease (COPD) is found to be widespread in China with almost 100 million people suffering from chronic lung disease according to a new Tulane University study published in 2018. The biggest preventable risk factors for the disease are cigarette smoking and air pollution and thus there are public-health priorities in China to reduce COPD-related diseases and deaths. Hence all these factors are expected to drive the overall market in China.
The healthcare reforms, such as acceleration of the basic medical insurance system, improvement in medical and health care service system, and universal access to basic public health services are some of the driving factors for the respiratory devices market in China.
Scope of the Report
As per the scope of the report, respiratory devices supplies the respiratory gas mechanically to the patients with impaired respiratory function. The respiratory gas is usually enriched with oxygen and conveyed into the lung with a positive pressure generated by the device. The respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia.
Key Market Trends
Spirometers is Anticipated to be the Dominant Segment in Diagnostic and Monitoring Devices during the Forecast Period
Spirometers help in the diagnosing the respiratory diseases, such as asthma, emphysema, bronchitis, and COPD. Furthermore, they can also be used to assess the shortness of breath, lung function before surgery, and the effect of medication.
The spirometers segment has been fueled by the recent technological advancements, in the field of spirometry that includes the development of small portable spirometers and the increasing accuracy, acceptability, and reproducibility of assessments with immediate feedback to the technician. Thus, the applications of spirometers make it easier for the patient to use this diagnostic device and is also increasingly adopted in hospitals and home care globally.
Vincent Medical is one of the major companies focusing on respiratory products across China. The other companies present in the market are found focusing on product innovations, expansions, finding new markets or innovating their core competency to expand their individual market share.
- Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
- Technological Advancements and Increasing Applications in Homecare Setting
- High Cost of Devices
Porter's Five Force Analysis
- DeVilbiss Healthcare LLC
- Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- GE Healthcare
- GlaxoSmithKline PLC
- Koninklijke Philips NV
- Medtronic PLC
- ResMed Inc.
- Invacare Corporation
For more information about this report visit https://www.researchandmarkets.com/r/5wh3j3